Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
ACS Chemical Biology|January 5, 2022
Small Molecule Calcium Channel Activator Potentiates Adjuvant ActivityTetsuya Saito, Nikunj M Shukla, Fumi Sato-Kaneko, et al.The Journal of Infectious Diseases|October 6, 2005
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 diseaseRobert C Kalayjian, John Spritzler, Minya Pu, et al.Journal of Medicinal Chemistry|August 8, 2024
Structure-Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine AdjuvantsMasiel M Belsuzarri, Yukiya Sako, Tyler D Brown, et al.The American Journal of Clinical Nutrition|April 3, 2009
Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living StudyJohn P Pierce, Loki Natarajan, Bette J Caan, et al.Proceedings of the National Academy of Sciences of the United States of America|June 3, 2021
Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infectionFumi Sato-Kaneko, Shiyin Yao, Fitzgerald S Lao, et al.BMC Bioinformatics|February 21, 2023
A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) StudyBrian Kwan, Tobias Fuhrer, Daniel Montemayor, et al.Frontiers in Immunology|July 9, 2020
A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal ReactogenicityFumi Sato-Kaneko, Shiyin Yao, Fitzgerald S Lao, et al.SLAS Discovery : Advancing Life Sciences R & D|May 13, 2018
Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine AdjuvantsNikunj M Shukla, Kei-Ichiro Arimoto, Shiyin Yao, et al.Frontiers in Immunology|October 15, 2021
Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral ChallengeTetsuya Saito, Yukiya Sako, Fumi Sato-Kaneko, et al.Journal of Virology|January 9, 2015
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responsesPeter H Goff, Tomoko Hayashi, Luis Martínez-Gil, et al.Pageof 8